We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $156B
1-Year Est. Return 27.51%
This Fund
S&P 500
This Quarter Est. Return
+5.98%
1 Year Est. Return
+27.51%
3 Year Est. Return
+75.53%
5 Year Est. Return
+102.92%
10 Year Est. Return
+480.77%
AUM
$42B
AUM Growth
+$2.37B
Cap. Flow
-$349M
Cap. Flow %
-0.83%
Top 10 Hldgs %
5.64%
Holding
1,947
New
155
Increased
870
Reduced
686
Closed
148

Top Buys

Rank Stock Value
1
VFC icon
VF Corp
VFC
+$139M
2
HOLX
Hologic
HOLX
+$133M
3
CE icon
Celanese
CE
+$132M
4
AJG icon
Arthur J. Gallagher & Co
AJG
+$117M
5
ALL icon
Allstate
ALL
+$116M

Sector Composition

Rank Sector Weight
1 Financials 17.54%
2 Industrials 15.03%
3 Technology 14.81%
4 Consumer Discretionary 9.52%
5 Healthcare 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RIGL icon
1726
Rigel Pharmaceuticals
RIGL
$681M
$23K ﹤0.01%
699
TGTX icon
1727
TG Therapeutics
TGTX
$7.96B
$23K ﹤0.01%
1,978
ACGN
1728
DELISTED
Aceragen Inc
ACGN
$23K ﹤0.01%
68
SGYP
1729
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$23K ﹤0.01%
4,929
+946
+24% +$5.49K
GPT
1730
DELISTED
Gramercy Property Trust
GPT
$23K ﹤0.01%
867
-35,802
-98% -$961K
DFT
1731
DELISTED
DuPont Fabros Technology Inc.
DFT
$23K ﹤0.01%
470
-1,500
-76% -$72.6K
CRIS icon
1732
Curis
CRIS
$9.78M
$22K ﹤0.01%
4
LXRX icon
1733
Lexicon Pharmaceuticals
LXRX
$1.03B
$22K ﹤0.01%
1,530
NVEE
1734
DELISTED
NV5 Global
NVEE
$22K ﹤0.01%
2,304
CBPO
1735
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$22K ﹤0.01%
216
+10
+5% +$1.07K
LCNB icon
1736
LCNB Corp
LCNB
$282M
$21K ﹤0.01%
865
FOMX
1737
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$21K ﹤0.01%
4,311
+2,313
+116% +$22.3K
WRI
1738
DELISTED
Weingarten Realty Investors
WRI
$19K ﹤0.01%
565
-1,050
-65% -$36.7K
CORI
1739
DELISTED
Corium International, Inc.
CORI
$19K ﹤0.01%
4,606
ACAD icon
1740
Acadia Pharmaceuticals
ACAD
$4.43B
$17K ﹤0.01%
504
CDTX
1741
DELISTED
Cidara Therapeutics
CDTX
$17K ﹤0.01%
108
+26
+32% +$4.57K
XLK icon
1742
State Street Technology Select Sector SPDR ETF
XLK
$115B
$17K ﹤0.01%
650
-700
-52% -$18K
ADXS
1743
DELISTED
Advaxis Inc
ADXS
$17K ﹤0.01%
139
+44
+46% +$5.71K
WPM icon
1744
Wheaton Precious Metals
WPM
$49.5B
$15K ﹤0.01%
698
AGEN
1745
Agenus
AGEN
$312M
$14K ﹤0.01%
185
HAIN icon
1746
Hain Celestial
HAIN
$45M
$13K ﹤0.01%
361
CCP
1747
DELISTED
Care Capital Properties, Inc.
CCP
$12K ﹤0.01%
456
-810
-64% -$20.4K
KDNY
1748
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$11K ﹤0.01%
207
QCP
1749
DELISTED
Quality Care Properties, Inc.
QCP
$11K ﹤0.01%
574
-1,198
-68% -$21.3K
ESPR
1750
DELISTED
Esperion Therapeutics
ESPR
$10K ﹤0.01%
277

Similar funds

Victory Capital Management's Q1 2017 Portfolio in Review

As of Q1 2017, Victory Capital Management held 1,947 positions worth $42B, up 6% from $39.6B the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.

Victory Capital Management's Q1 2017 filing shows 155 new, 870 increased, 686 reduced and 148 closed positions. Its largest new stake was Celanese: 1,512,133 shares worth $136M. The largest sale was Acuity Brands, an estimated $114M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Industrials and Technology.

  • Victory Capital Management's largest Q1 2017 buy was Celanese: 1,512,133 shares worth $136M.
  • Victory Capital Management added most to VF Corp in Q1 2017, an estimated $139M increase.
  • Victory Capital Management's biggest Q1 2017 reduction was Acuity Brands, cutting an estimated $114M.
  • Victory Capital Management fully exited Mentor Graphics Corp in Q1 2017, selling an estimated $53.4M.
  • Victory Capital Management's ten largest holdings make up 5.6% of its $42B portfolio in Q1 2017.
  • Victory Capital Management opened 155 new positions and closed 148 in Q1 2017.
  • Victory Capital Management's portfolio value rose 6% quarter-over-quarter to $42B.

Based on Victory Capital Management's 13F filing for Q1 2017, filed 10 May 2017.